Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 101, Issue 3, 2013, Pages 341-348

  Song, Young Sook ^a   Lee, Seul Ki ^a   Jang, Yeon Jin ^a   Park, Hye Soon ^a   Kim, Jong Hyeok ^a   Lee, Yeon Ji ^b   Heo, Yoon Suk ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Inha University School of Medicine   (South Korea)

Author keywords

Adiponectin; Adipose tissue; Insulin resistance; SIRT1; Visceral obesity

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; SIRTUIN 1; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADIPOCYTE; ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE INDEX; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; METABOLIC DISORDER; METABOLIC REGULATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH BYPASS; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADIPOSE TISSUE; INSULIN RESISTANCE; SIRT1; VISCERAL OBESITY;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; SIRTUIN 1; SUBCUTANEOUS FAT;

EID: 84885384180     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.07.002     Document Type: Article

References (31)

1. Imai S., Johnson F.B., Marciniak R.A., McVey M., Park P.U., Guarente L. Sir2: an NAD-dependent histone deacetylase that connects chromatin silencing, metabolism, and aging. Cold Spring Harb Symp Quant Biol 2000, 65:297-302.
2. Chen D., Steele A.D., Lindquist S., Guarente L. Increase in activity during calorie restriction requires Sirt1. Science 2005, 310:1641.
3. Yang T., Fu M., Pestell R., Sauve A.A. SIRT1 and endocrine signaling. Trends Endocrinol Metab 2006, 17:186-191.
4. Leibiger I.B., Berggren P.O. Sirt1: a metabolic master switch that modulates lifespan. Nat Med 2006, 12:34-36. discussion 6.
5. Bays H.E., Gonzalez-Campoy J.M., Bray G.A., Kitabchi A.E., Bergman D.A., Schorr A.B., et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008, 6:343-368.
6. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004, 429:771-776.
7. Qiang L., Wang H., Farmer S.R. Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol Cell Biol 2007, 27:4698-4707.
8. Qiao L., Shao J. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem 2006, 281:39915-39924.
9. Gillum M.P., Kotas M.E., Erion D.M., Kursawe R., Chatterjee P., Nead K.T., et al. SirT1 regulates adipose tissue inflammation. Diabetes 2011, 60:3235-3245.
10. Cho K.W., Lumeng C.N. SirT1: a guardian at the gates of adipose tissue inflammation. Diabetes 2011, 60:3100-3102.
11. Yoshizaki T., Milne J.C., Imamura T., Schenk S., Sonoda N., Babendure J.L., et al. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 2009, 29:1363-1374.
12. Yoshizaki T., Schenk S., Imamura T., Babendure J.L., Sonoda N., Bae E.J., et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 2010, 298:E419-E428.
13. Banks A.S., Kon N., Knight C., Matsumoto M., Gutierrez-Juarez R., Rossetti L., et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab 2008, 8:333-341.
14. Feige J.N., Lagouge M., Canto C., Strehle A., Houten S.M., Milne J.C., et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 2008, 8:347-358.
15. Pfluger P.T., Herranz D., Velasco-Miguel S., Serrano M., Tschop M.H. Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 2008, 105:9793-9798.
16. Pedersen S.B., Olholm J., Paulsen S.K., Bennetzen M.F., Richelsen B. Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women. Int J Obes (Lond) 2008, 32:1250-1255.
17. Rutanen J., Yaluri N., Modi S., Pihlajamaki J., Vanttinen M., Itkonen P., et al. SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes 2010, 59:829-835.
18. Kvist H., Chowdhury B., Grangard U., Tylen U., Sjostrom L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988, 48:1351-1361.
19. Yoshizumi T., Nakamura T., Yamane M., Islam A.H., Menju M., Yamasaki K., et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999, 211:283-286.
20. Fujioka S., Matsuzawa Y., Tokunaga K., Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987, 36:54-59.
21. Zamboni M., Armellini F., Milani M.P., Todesco T., De Marchi M., Robbi R., et al. Evaluation of regional body fat distribution: comparison between W/H ratio and computed tomography in obese women. J Intern Med 1992, 232:341-347.
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
23. Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010, 11:11-18.
24. Mei C., Sun L., Liu Y., Yang Y., Cai X., Liu M., et al. Transcriptional and post-transcriptional control of DNA methyltransferase 3B is regulated by phosphatidylinositol 3 kinase/Akt pathway in human hepatocellular carcinoma cell lines. J Cell Biochem 2010, 111:158-167.
25. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749.
26. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996, 221:286-289.
27. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
28. Lear S.A., Humphries K.H., Kohli S., Chockalingam A., Frohlich J.J., Birmingham C.L. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 2007, 86:353-359.
29. Park Y.W., Allison D.B., Heymsfield S.B., Gallagher D. Larger amounts of visceral adipose tissue in Asian Americans. Obes Res 2001, 9:381-387.
30. Han J.H., Park H.S., Kim S.M., Lee S.Y., Kim D.J., Choi W.H. Visceral adipose tissue as a predictor for metabolic risk factors in the Korean population. Diab Med 2008, 25:106-110.
31. McKeigue P.M., Shah B., Marmot M.G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991, 337:382-386.